Investment
Participated in Scala Biodesign's $16M Series A for AI-driven protein design, led by Grove Ventures.
Scala Biodesign
Every public signal F4 has attached to this firm, with sources and cross-entity links.
Scala Biodesign
Addionics
GreenEye Technology